ARCHIMEDlife News
ARCHIMEDlife and Blueprint Genetics form a partnership in North America
25. September 2019
Combining high-quality biochemical testing with innovative genetic testing forms a powerful tool for personalized medicine, clinical research and diagnostics...
Read more
SSIEM @ Rotterdam
27. August 2019
Exciting! Our booth with a brand new look and novel, innovative portfolio of diagnostic tests and services. First time...
Read more
New cut-offs for lysosomal enzyme activities.
6. Juni 2019
We are happy to inform you that we have introduced a new diagnostic assay for the analysis of lysosomal...
Read more
TDM für Psychopharmaka: (in German)
26. Februar 2019
Quantitative Bestimmung von Psychopharmaka in Blut, Serum oder Plasma Modernste Analysetechnik mittels Klinischer Massenspektrometrie (exakt, sensitiv, schnell) Kompetente fachärztliche Auskunft...
Read more
Improving our ability to diagnose Hemoglobinopathies.
1. Oktober 2018
Results of a prospective study using High-Resolution Mass Spectrometry. The goal of our study, in cooperation with the University...
Read more
Novel diagnostics for Rare Disorders: Fabry in females, presented at WorldSymposium
7. März 2018
The parallel measurement of lyso-GL-3 (lyso-Gb3) for Fabry disease is of high importance particularly for potential female Fabry patients,...
Read more
5 years ARCHIMEDlife – Thanks to our partners, clients and friends!
21. November 2017
The 21st of November 2017 is ARCHIMEDlife´s 5th anniversary, a proof that out of an idea you can evolve...
Read more
Become part of our readers´ community
12. November 2017
You can easily subscribe to our bi-monthly ARCHIMEDlife Newsletter and read about laboratory diagnostics, research studies, scientific publications and...
Read more
We were there: Asia-Pacific Conference on Human Genetics
6. November 2017
We took part in the 12th Asia-Pacific Conference on Human Genetics “Genomic Medicine and Clinical Practice” from 8th to...
Read more